Hemab Therapeutics COAG

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

• 4Sept. 25, 2026, 4:45 p.m. ETView on SEC.gov
• 8-KSept. 24, 2026, 4:03 p.m. ETView on SEC.gov

  Departure/appointment of directors or officers

• SCHEDULE 13GAug. 14, 2026, 5:05 p.m. ETView on SEC.gov
• SCHEDULE 13GAug. 14, 2026, 9:01 a.m. ETView on SEC.gov
• SCHEDULE 13GAug. 12, 2026, 10:28 a.m. ETView on SEC.gov
• 10-QAug. 11, 2026, 4 p.m. ETView on SEC.gov
• 8-KAug. 11, 2026, 7:11 a.m. ETView on SEC.gov

  Results of operations and financial condition · Financial statements and exhibits

• SCHEDULE 13GAug. 7, 2026, 9:31 a.m. ETView on SEC.gov